These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18638486

  • 1. Structural determinants of the ADAM inhibition by TIMP-3: crystal structure of the TACE-N-TIMP-3 complex.
    Wisniewska M, Goettig P, Maskos K, Belouski E, Winters D, Hecht R, Black R, Bode W.
    J Mol Biol; 2008 Sep 19; 381(5):1307-19. PubMed ID: 18638486
    [Abstract] [Full Text] [Related]

  • 2. Mapping and characterization of the functional epitopes of tissue inhibitor of metalloproteinases (TIMP)-3 using TIMP-1 as the scaffold: a new frontier in TIMP engineering.
    Lee MH, Maskos K, Knäuper V, Dodds P, Murphy G.
    Protein Sci; 2002 Oct 19; 11(10):2493-503. PubMed ID: 12237470
    [Abstract] [Full Text] [Related]

  • 3. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
    Lee MH, Dodds P, Verma V, Maskos K, Knäuper V, Murphy G.
    Biochem J; 2003 Apr 15; 371(Pt 2):369-76. PubMed ID: 12556225
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
    Lee MH, Verma V, Maskos K, Nath D, Knäuper V, Dodds P, Amour A, Murphy G.
    Biochem J; 2002 May 15; 364(Pt 1):227-34. PubMed ID: 11988096
    [Abstract] [Full Text] [Related]

  • 6. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3.
    Lee MH, Verma V, Maskos K, Becherer JD, Knäuper V, Dodds P, Amour A, Murphy G.
    FEBS Lett; 2002 Jun 05; 520(1-3):102-6. PubMed ID: 12044879
    [Abstract] [Full Text] [Related]

  • 7. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2005 Apr 22; 280(16):15967-75. PubMed ID: 15713681
    [Abstract] [Full Text] [Related]

  • 8. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.
    Lee MH, Knäuper V, Becherer JD, Murphy G.
    Biochem Biophys Res Commun; 2001 Jan 26; 280(3):945-50. PubMed ID: 11162616
    [Abstract] [Full Text] [Related]

  • 9. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
    Lee MH, Rapti M, Murphy G.
    J Biol Chem; 2004 Oct 22; 279(43):45121-9. PubMed ID: 15308656
    [Abstract] [Full Text] [Related]

  • 10. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
    Wei S, Xie Z, Filenova E, Brew K.
    Biochemistry; 2003 Oct 28; 42(42):12200-7. PubMed ID: 14567681
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
    Kveiborg M, Jacobsen J, Lee MH, Nagase H, Wewer UM, Murphy G.
    Biochem J; 2010 Aug 15; 430(1):79-86. PubMed ID: 20533908
    [Abstract] [Full Text] [Related]

  • 12. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H, Maskos K.
    EMBO J; 1998 Sep 01; 17(17):5238-48. PubMed ID: 9724659
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-10 regulates TNF-alpha-converting enzyme (TACE/ADAM-17) involving a TIMP-3 dependent and independent mechanism.
    Brennan FM, Green P, Amjadi P, Robertshaw HJ, Alvarez-Iglesias M, Takata M.
    Eur J Immunol; 2008 Apr 01; 38(4):1106-17. PubMed ID: 18383040
    [Abstract] [Full Text] [Related]

  • 14. Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
    Lim NH, Kashiwagi M, Visse R, Jones J, Enghild JJ, Brew K, Nagase H.
    Biochem J; 2010 Oct 01; 431(1):113-22. PubMed ID: 20645923
    [Abstract] [Full Text] [Related]

  • 15. Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.
    Maskos K, Lang R, Tschesche H, Bode W.
    J Mol Biol; 2007 Mar 02; 366(4):1222-31. PubMed ID: 17196980
    [Abstract] [Full Text] [Related]

  • 16. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
    Wu D, Gu Q, Zhao N, Xia F, Li Z.
    J Drug Target; 2015 Dec 02; 23(10):936-42. PubMed ID: 26061299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
    Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knäuper V, Docherty AJ, Murphy G.
    FEBS Lett; 1998 Sep 11; 435(1):39-44. PubMed ID: 9755855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.